337 related articles for article (PubMed ID: 7540236)
1. Cytokeratin patterns of liver carcinomas induced by diethylnitrosamine in monkeys.
Lapis K; Sarosi I; Bocsi J; Thorgeirsson UP
Lab Invest; 1995 Jun; 72(6):748-59. PubMed ID: 7540236
[TBL] [Abstract][Full Text] [Related]
2. The diagnostic value of cytokeratins and carcinoembryonic antigen immunostaining in differentiating hepatocellular carcinomas from intrahepatic cholangiocarcinomas.
Stroescu C; Herlea V; Dragnea A; Popescu I
J Gastrointestin Liver Dis; 2006 Mar; 15(1):9-14. PubMed ID: 16680226
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric DNA-ploidy and proliferative activity of diethylnitrosamine-induced hepatocellular carcinoma and pulmonary metastases in monkeys.
Lapis K; Bocsi J; Lapis P; Thorgeirsson UP
Hepatology; 1995 Sep; 22(3):952-61. PubMed ID: 7657303
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical profiles of Mallory body by a panel of anti-cytokeratin antibodies.
Pei RJ; Danbara N; Tsujita-Kyutoku M; Yuri T; Tsubura A
Med Electron Microsc; 2004 Jun; 37(2):114-8. PubMed ID: 15221653
[TBL] [Abstract][Full Text] [Related]
5. Studies on the proliferative activity of diethylnitrosamine-induced hepatocellular carcinomas in monkeys.
Lapis K; Bocsi J; Timar F; Lapis P; Thorgeirsson UP
J Pathol; 1997 Apr; 181(4):439-43. PubMed ID: 9196443
[TBL] [Abstract][Full Text] [Related]
6. The expression of cytokeratins 7, 19, and 20 in primary and metastatic carcinomas of the liver.
Maeda T; Kajiyama K; Adachi E; Takenaka K; Sugimachi K; Tsuneyoshi M
Mod Pathol; 1996 Sep; 9(9):901-9. PubMed ID: 8878022
[TBL] [Abstract][Full Text] [Related]
7. Utilization of antihepatocyte clone OCH1E5 (Hep Par 1) in histological evaluation of liver tumors.
Amarapurkar AD; Rege JD; Joshi AS; Vaiphei K; Amarapurkar DN
Indian J Pathol Microbiol; 2006 Jul; 49(3):341-4. PubMed ID: 17001880
[TBL] [Abstract][Full Text] [Related]
8. Antigenic relationship between oval cells and a subpopulation of hepatic foci, nodules, and carcinomas induced by the "resistant hepatocyte" model system.
Faris RA; Monfils BA; Dunsford HA; Hixson DC
Cancer Res; 1991 Feb; 51(4):1308-17. PubMed ID: 1997169
[TBL] [Abstract][Full Text] [Related]
9. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
10. Different lineages of chemically induced hepatocellular carcinoma in rats defined by monoclonal antibodies.
Dunsford HA; Karnasuta C; Hunt JM; Sell S
Cancer Res; 1989 Sep; 49(17):4894-900. PubMed ID: 2474377
[TBL] [Abstract][Full Text] [Related]
11. Spontaneously occurring hepatocellular neoplasia in adolescent cynomolgus monkeys (Macaca fascicularis).
Reindel JF; Walsh KM; Toy KA; Bobrowski WF
Vet Pathol; 2000 Nov; 37(6):656-62. PubMed ID: 11105957
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic significance of aquaporin-1 in liver tumors.
Mazal PR; Susani M; Wrba F; Haitel A
Hum Pathol; 2005 Nov; 36(11):1226-31. PubMed ID: 16260277
[TBL] [Abstract][Full Text] [Related]
13. Keratin polypeptides in malignant epithelial liver tumors. Differential diagnostic and histogenetic aspects.
Fischer HP; Altmannsberger M; Weber K; Osborn M
Am J Pathol; 1987 Jun; 127(3):530-7. PubMed ID: 2438941
[TBL] [Abstract][Full Text] [Related]
14. The Sialyl Lewis X expression in hepatocarcinogenesis: potential predictor for the emergence of hepatocellular carcinoma.
Fujiwara Y; Shimada M; Takenaka K; Kajiyama K; Shirabe K; Sugimachi K
Hepatogastroenterology; 2002; 49(43):213-7. PubMed ID: 11941958
[TBL] [Abstract][Full Text] [Related]
15. Distribution of cytokeratin 19-positive biliary cells in cirrhotic nodules, hepatic borderline nodules (atypical adenomatous hyperplasia), and small hepatocellular carcinomas.
Terada T; Hoso M; Nakanuma Y
Mod Pathol; 1995 May; 8(4):371-9. PubMed ID: 7567933
[TBL] [Abstract][Full Text] [Related]
16. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma.
Lau SK; Prakash S; Geller SA; Alsabeh R
Hum Pathol; 2002 Dec; 33(12):1175-81. PubMed ID: 12514785
[TBL] [Abstract][Full Text] [Related]
17. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
Tátrai P
Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
[TBL] [Abstract][Full Text] [Related]
18. HCC CKs are altered histones during tumor transformation in hepatoma.
Liu YH; Pei RJ; Cheng CC; Ho HC; Ho CC; Yeh KT; Lee KY; Lai YS
Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):27-38. PubMed ID: 15080494
[TBL] [Abstract][Full Text] [Related]
19. C-erb-B-2 oncoprotein and epidermal growth factor receptor in human hepatocellular carcinoma: an immunohistochemical study.
Nakopoulou L; Stefanaki K; Filaktopoulos D; Giannopoulou I
Histol Histopathol; 1994 Oct; 9(4):677-82. PubMed ID: 7894139
[TBL] [Abstract][Full Text] [Related]
20. Comparative immunohistochemical expression of p63 in human cholangiocarcinoma and hepatocellular carcinoma.
Ramalho FS; Ramalho LN; Della Porta L; Zucoloto S
J Gastroenterol Hepatol; 2006 Aug; 21(8):1276-80. PubMed ID: 16872309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
